Khayumbi J, Sasser L, McLaughlin T, Ongalo J, Tonui J, Ouma S
Tuberculosis (Edinb). 2025; 151:102607.
PMID: 39864237
PMC: 11871988.
DOI: 10.1016/j.tube.2025.102607.
Njagi L, Nduba V, Murithi W, Mwongera Z, Cook K, Mecha J
Sci Rep. 2025; 15(1):224.
PMID: 39748008
PMC: 11695726.
DOI: 10.1038/s41598-024-83965-5.
Setiabudiawan T, Apriani L, Verrall A, Utami F, Schneider M, Indrati A
Nat Commun. 2025; 16(1):309.
PMID: 39747050
PMC: 11695729.
DOI: 10.1038/s41467-024-55501-6.
Zhou S, Cao Q, Zhang Z, Du Y, Hou Y, Zhang X
NPJ Vaccines. 2024; 9(1):248.
PMID: 39702587
PMC: 11659584.
DOI: 10.1038/s41541-024-01049-x.
Njagi L, Nduba V, Murithi W, Mwongera Z, Cook K, Mecha J
Res Sq. 2024; .
PMID: 39606489
PMC: 11601854.
DOI: 10.21203/rs.3.rs-4815117/v1.
MTBVAC induces superior antibody titers and IgG avidity compared to BCG vaccination in non-human primates.
Peralta-Alvarez M, Downward K, White A, Azema H, Sibley L, Sarfas C
NPJ Vaccines. 2024; 9(1):230.
PMID: 39567530
PMC: 11579480.
DOI: 10.1038/s41541-024-01009-5.
Cell-autonomous targeting of arabinogalactan by host immune factors inhibits mycobacterial growth.
Qin L, Xu J, Chen J, Wang S, Zheng R, Cui Z
Elife. 2024; 13.
PMID: 39495223
PMC: 11534329.
DOI: 10.7554/eLife.92737.
Immune correlates of protection as a game changer in tuberculosis vaccine development.
Wang J, Fan X, Hu Z
NPJ Vaccines. 2024; 9(1):208.
PMID: 39478007
PMC: 11526030.
DOI: 10.1038/s41541-024-01004-w.
TubIAgnosis: A machine learning-based web application for active tuberculosis diagnosis using complete blood count data.
Ghermi M, Messedi M, Adida C, Belarbi K, Djazouli M, Berrazeg Z
Digit Health. 2024; 10:20552076241278211.
PMID: 39224791
PMC: 11367613.
DOI: 10.1177/20552076241278211.
Biomarkers in diagnosing and therapeutic monitoring of tuberculosis: a review.
Leo S, Narasimhan M, Rathinam S, Banerjee A
Ann Med. 2024; 56(1):2386030.
PMID: 39097795
PMC: 11299445.
DOI: 10.1080/07853890.2024.2386030.
Recasting resistance to Mycobacterium tuberculosis.
Andrews J
Nat Immunol. 2024; 25(8):1316-1318.
PMID: 39048789
DOI: 10.1038/s41590-024-01907-9.
Specific CD4 T cell phenotypes associate with bacterial control in people who 'resist' infection with Mycobacterium tuberculosis.
Sun M, Phan J, Kieswetter N, Huang H, Yu K, Smith M
Nat Immunol. 2024; 25(8):1411-1421.
PMID: 38997431
PMC: 11291275.
DOI: 10.1038/s41590-024-01897-8.
Impact of exposure to HIV and latent TB on infant humoral responses.
Hjelmar K, de Armas L, Goldberg E, Pallikkuth S, Mathad J, Montepiedra G
Front Immunol. 2024; 15:1423435.
PMID: 38994354
PMC: 11236605.
DOI: 10.3389/fimmu.2024.1423435.
Heterogeneity in lung macrophage control of Mycobacterium tuberculosis is modulated by T cells.
Lai R, Williams T, Rakib T, Lee J, Behar S
Nat Commun. 2024; 15(1):5710.
PMID: 38977711
PMC: 11231272.
DOI: 10.1038/s41467-024-48515-7.
Airway microbiome signature accurately discriminates infection status.
Kayongo A, Ntayi M, Olweny G, Kyalo E, Ndawula J, Ssengooba W
iScience. 2024; 27(6):110142.
PMID: 38904070
PMC: 11187240.
DOI: 10.1016/j.isci.2024.110142.
Tuberculin skin test surveys and the Annual Risk of Tuberculous Infection in school children in Northern KwaZulu-Natal.
Yates T, Cebekhulu S, Mthethwa M, Fourie P, Newell M, Abubakar I
PLOS Glob Public Health. 2024; 4(6):e0003263.
PMID: 38889188
PMC: 11185501.
DOI: 10.1371/journal.pgph.0003263.
B cell heterogeneity in human tuberculosis highlights compartment-specific phenotype and functional roles.
Krause R, Ogongo P, Tezera L, Ahmed M, Mbano I, Chambers M
Commun Biol. 2024; 7(1):584.
PMID: 38755239
PMC: 11099031.
DOI: 10.1038/s42003-024-06282-7.
Evaluation of serological assays for the diagnosis of childhood tuberculosis disease: a study protocol.
Neudecker D, Fritschi N, Sutter T, Lu L, Lu P, Tebruegge M
BMC Infect Dis. 2024; 24(1):481.
PMID: 38730343
PMC: 11084122.
DOI: 10.1186/s12879-024-09359-0.
MR1-restricted T cell clonotypes are associated with "resistance" to Mycobacterium tuberculosis infection.
Cross D, Layton E, Yu K, Smith M, Aguilar M, Li S
JCI Insight. 2024; 9(9).
PMID: 38716731
PMC: 11141901.
DOI: 10.1172/jci.insight.166505.
High-parameter phenotypic characterization reveals a subset of human Th17 cells that preferentially produce IL-17 against antigen.
Ogongo P, Tran A, Marzan F, Gingrich D, Krone M, Aweeka F
Front Immunol. 2024; 15:1378040.
PMID: 38698866
PMC: 11064812.
DOI: 10.3389/fimmu.2024.1378040.